CHEYENNE HARRIS: Open Payments
NPI 1316670540 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 5 payments from 4 companies in 2025. Trend: 2023 $125 · 2024 $121 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $219 |
| Syndax Pharmaceuticals, Inc. | 1 | $127 |
| Astellas Pharma US Inc | 1 | $121 |
| Janssen Biotech, Inc. | 1 | $114 |
Products named: VENCLEXTA, REVUFORJ, Cresemba, RYBREVANT.
Industry payments across PA — which companies pay providers there.
